Tricuspid Regurgitation (TR) after Implantation of a Cardiac Implantable Electronic Device (CIED)—One-Year Observation of Patients with or without Left Ventricular Dysfunction
Open Access
- 19 August 2023
- journal article
- research article
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 10 (8) , 353
Abstract
The frequency of tricuspid regurgitation (TR) progression after cardiac implantable electronic devices (CIEDs) implantation varies from 7.2% to 44.7%. TR is associated with increased mortality and hospitalizations due to heart failure (HF) decompensation. The aim of this study was to assess the rate of early TR progression after CIED implantation and the frequency of HF decompensation and mortality. The 101 patients, who received a CIED between March 2020 and October 2021, before the procedure were divided into two groups–one with left ventricle ejection fraction (LVEF) ≥ 40% (n = 60) and one with LVEF < 40% (n = 41). Lead-related tricuspid regurgitation (LRTR) was defined as an increase of TR by at least one grade. The follow-up period was similar between both groups and was on average 13 (12–16) months. In the whole study group, TR progression by one grade was 34.6% and by two or more grades 15.8%. The significant changes in the dynamic of TR degree were as follows before and after implantation: none/trivial TR in group 1 (61.7% vs. 28.3%, p = 0.01) and severe/massive TR in group 2 (0.0% vs. 14.6%, p = 0.03). The groups did not differ from each other in terms of survival from decompensation of HF (18.3% vs. 36.6%, p = 0.70) and survival from death (1.7% vs. 4.9%, p = 0.16). At the one-year follow-up, the baseline LVEF did not affect the survival rate from death or HF decompensation among patients with a progression of TR after CIED implantation. In this study, a progression by one grade was more common in group 1, but the occurrence of severe/massive TR after implantation was more specific for group 2.Keywords
This publication has 51 references indexed in Scilit:
- Functional tricuspid regurgitation: An underestimated issueInternational Journal of Cardiology, 2013
- Induction and aggravation of atrioventricular valve regurgitation in the course of chronic right ventricular apical pacingEP Europace, 2011
- Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator—the EVADEF studyAmerican Heart Journal, 2010
- Tricuspid Incompetence Following Permanent Pacemaker ImplantationPacing and Clinical Electrophysiology, 2009
- Permanent pacemaker implantation technique: part IIHeart, 2009
- Functional Tricuspid Regurgitation in Patients With Pulmonary HypertensionChest, 2009
- The Effect of Transvenous Pacemaker and Implantable Cardioverter Defibrillator Lead Placement on Tricuspid Valve Function: An Observational StudyJournal of the American Society of Echocardiography, 2008
- Impact of transvenous ventricular pacing leads on tricuspid regurgitation in pediatric and congenital heart disease patientsJournal of Interventional Cardiac Electrophysiology, 2007
- Severe Symptomatic Tricuspid Valve Regurgitation Due to Permanent Pacemaker or Implantable Cardioverter-Defibrillator LeadsJACC, 2005
- Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)The American Journal of Cardiology, 1999